Defense Health Research Consortium: Restore Funding for CDMRP
Restore Our Research!
Reverse the 57% Cut to Congressionally Directed Medical Research Program
CDMRP Benefits the Armed Services and General Public
- Every medical research program at CDMRP directly impacts the health and lives of the U.S. military, their families, veterans and the public.
- Programs provide groundbreaking research on cancer, psychological health, Gulf War Illness, respiratory health, burn pits and other toxic exposures, spinal cord injury, and hearing and vision loss, and newer conditions such as Long COVID.
- CDMRP grants neither duplicate nor supplant NIH or VA research efforts, but rather enhance those efforts. They fund highly innovative projects – support that is typically unavailable through other federal programs.
- Research breakthroughs have led to new clinical trials, new drug products, and novel procedures that are making a difference in the everyday lives of patients and families.
Cuts to CDMRP Harm National Security and Threaten U.S. Biomedical Research Pre-eminence
- The recently-enacted fiscal year 2025 Continuing Resolution cuts funding for CDMRP by $859 million, from $1.509 billion to $650 million – a 57 percent cut from FY24 levels.
- Cuts of this magnitude will significantly disrupt research into new therapeutics for diseases and disorders that impact the men and women in the Armed Services, as well as veterans, military families and the general public.
- Combined with recent cuts and grant freezes at NIH, the recently-enacted cuts to CDMRP threaten the U.S. position as the global leader in biomedical research, ceding our competitive advantage to China and other global competitors.
- Congress must work in a bipartisan way to restore these cuts to CDMRP and increase FY26 funding for the program to ensure that our country is prepared to meet current and future public health-related threats and challenges to our national security.
Please Support Legislation to restore the 57% cut to CDMRP!